Pregnant women admitted to hospital after a collision-related MVA tend to sustain less severe injuries compared to non-pregnant women. However, the influence of admissions for fetal monitoring, rather than maternal injury, could not be determined from our dataset. Pregnant women who experienced a collision-related MVA also required less surgical intervention, with the exception of genitourinary surgery, which may be indicative of more cesarean deliveries.

Robot-assisted gynecologic surgery is performed with a pneumoperitoneum and prolonged maximum Trendelenburg position which can result in adverse physiologic effects. The purpose of this study was to assess the feasibility of robot-assisted gynecologic oncology procedures and to identify anesthesia-related peri-operative adverse events. This is a case series performed on the first 133 patients who underwent a robot-assisted gynecologic oncology procedure at a tertiary care facility. Data was collected from electronically archived patient charts and from a prospective surgical database. Patient demographics were recorded and significant intra-operative and post-operative adverse events were reviewed. Robot-assisted surgery for gynecologic oncologic surgery with the use of extreme Trendelenburg in all patients was safely and successfully performed across a wide range of ages, American Society of Anesthesiologists physical status scores and body mass indices. Although most patients developed various degree of facial edema, only 5% of patients had a delayed extubation. Transient intra-operative hypoxemia (O2 saturation < 90%) occurred in 3.75% (5/133) of patients and hypercapnia (CO2 > 45 mmHg) in 18% (24/133). The mean duration of surgery was 254 min and median hospital stay was 1 day. Anesthetic and peri-operative complications are rare for patients undergoing robot-assisted gynecologic oncology surgeries despite the prolonged use of maximum Trendelenburg positioning and pneumoperitoneum. Although there are new anesthetic challenges, these surgeries were safely performed in a wide range of patients with minimal blood loss, short hospital stay and no significant cardiopulmonary complications.

fat tissues across the whole body. This pilot study was undertaken to see what correlation exists between BMI and percentile body fat in a cohort of postmenopausal women.MATERIALS AND METHODS: Fifty postmenopausal women who had a routine dual x-ray absorptiometry scan for bone mass indication and who had had whole-body scans for body composition were collected retrospectively and consecutively. GE Lunar Core Scan software was utilized. Percentile for body fat for age and female sex was calculated from the GE/LUNAR database. This was then compared with their BMI calculated by measuring their height and weight. Standard BMI definitions were used. Percentile body fat from the 25th to 75th percentile was considered normal, whereas greater than the 75th percentile was "abnormal" and less than the 25th percentile was "lean."RESULTS: A total of 18.5% of normal-weight postmenopausal women had a body fat greater than the 75th percentile. A total of 23.1% of overweight postmenopausal women had a body fat that was normal; 22.2% of normal-weight postmenopausal women had a body fat that was less than the 25th percentile. One hundred percent of obese postmenopausal women had body fat that was greater than the 75th percentile.CONCLUSION: Dual x-ray absorptiometry determination of body fat percentile in this pilot study seems like a reasonable and probable surrogate for metabolic health that is more accurate than BMI. Further prospective study is indicated. INTRODUCTION:We previously presented a survey of U.S. obstetrician-gynecologists (ob-gyns) and primary care physicians showing that physicians who have a strong level of knowledge about large randomized trials of menopausal hormone therapy (HT) are more likely to prescribe menopausal HT compared with physicians who have less knowledge of these trials. We examine this relationship in the ob-gyn subgroup of respondents.METHODS: Through a double-blind Internet-based survey, knowledge was assessed through nine statements about menopausal HT trials (response scale: true, false, or do not know [range 0-9]) and enthusiasm was assessed through six case studies (7-point response scale of "extremely likely" to "extremely unlikely" in relation to treatment [range 6-42]). Higher scores correspond to greater knowledge or enthusiasm. The primary analysis examined the correlation between clinical trial knowledge and enthusiasm for initiating or continuing menopausal HT. RESULTS: Among 250 ob-gyns surveyed (median age 53.0 years; 30.4% female; median 21.0 years in practice), there was a statistically significant, moderate positive correlation (0.24, 95% confidence interval 0.12-0.35, P,.001) between knowledge (mean [standard deviation {SD}] 5.1 [2.0]) and enthusiasm (mean [SD] 26.3 [5.4]). Level of knowledge was similar for male and female ob-gyns (mean [standard error] 4.5 [0.29] compared with 4.4 [0.34]; P5.741); however, men showed greater enthusiasm for prescribing menopausal HT (26.9 [0.80] compared with 25.3 [0.93], effect size 0.31 [small to moderate], P5.003). Knowledge significantly...